Acorda Therapeutics Inc.

NASDAQ: ACOR · Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM

Acorda Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.36M 37.54M 45.63M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
255K 255K 6.19M
Other Long-Term Assets
4.19M -42.78M -82.45M
Receivables
17.3M 13.87M 17M
Inventory
16.16M 12.75M 18.55M
Other Current Assets
10.98M 11.08M 7.57M
Total Current Assets
74.79M 82.11M 102.16M
Property-Plant & Equipment
6.3M 7.89M 11.13M
Goodwill & Intangibles
22.99M 305.09M 335.98M
Total Long-Term Assets
42.95M 313.48M 353.31M
Total Assets
117.75M 395.6M 455.47M
Account Payables
13.37M 10.09M 11.81M
Deferred Revenue
227K 384K 27.64M
Short-Term Debt
187.73M 1.54M 8.19M
Other Current Liabilities
26.44M 25.93M 6.39M
Total Current Liabilities
227.77M 37.95M 54.02M
Long-Term Debt
3.17M 171.37M 182.76M
Other Long-Term Liabilities
35.54M 48.45M 53.59M
Total Long-Term Liabilities
47.93M 264.02M 250.31M
Total Liabilities
275.7M 301.97M 304.33M
Total Debt
190.9M 172.92M 190.94M
Common Stock
1K 24K 13K
Retained Earnings
-1.19B -936.27M -870.36M
Comprehensive Income
1.43M 628K -1.02M
Shareholders Equity
-157.96M 93.62M 151.14M
Total Investments
255K 255K 6.19M